|
Volumn 64, Issue 2, 2007, Pages 133-134
|
Compliance with guidelines for treating sepsis [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CEPHALOSPORIN DERIVATIVE;
LEVOFLOXACIN;
PIPERACILLIN PLUS TAZOBACTAM;
ADULT;
AGED;
ANTIBIOTIC THERAPY;
BACTEREMIA;
BACTERIUM CULTURE;
CANDIDA;
CLINICAL ARTICLE;
CLINICAL PRACTICE;
COHORT ANALYSIS;
COMBINATION CHEMOTHERAPY;
DISEASE SEVERITY;
DRUG CHOICE;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HEALTH CARE PLANNING;
HUMAN;
INTENSIVE CARE UNIT;
LEGIONELLA;
LETTER;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MONOTHERAPY;
NONHUMAN;
OUTCOMES RESEARCH;
PHARMACIST;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
SEPSIS;
SEPTIC SHOCK;
TREATMENT OUTCOME;
|
EID: 33947145591
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/ajhp060174 Document Type: Letter |
Times cited : (4)
|
References (1)
|